(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. nlk and lef1 cooperatively regulate tbx6, and
nlk regulates lef1 expression. (A-D) tbx6
expression at 60% epiboly, lateral view, dorsal to the right. A low dose (0.6
ng) of nlk MO has no effect on tbx6 expression (B, compare
with wild type in A). 1 ng lef1 MO reduces tbx6 expression
(C), and this effect is enhanced by co-injection of 0.6 ng nlk MO
(D). (E-H) Expression of lef1 at shield stage, lateral view, dorsal
to the right. lef1 is expressed at the margin in wild type (E), but
is reduced in nlk MO (F). lef1 expression is dramatically
elevated in tcf3a/tcf3b morphants (G) and in nlk/tcf3a/tcf3b
MO embryos (H). (I-L) nlk or lef1 RNA rescues tbx6
expression in nlk morphants. nlk* RNA refers to
the C387Y mutant. Co-injection of 200pg nlk RNA (K), but not
nlk* RNA (J), restores tbx6 expression to levels
similar to wild type (I). 100pg lef1 RNA (L) also rescues
nlk morphants. Similarly, nlk RNA rescues normal
lef1 expression (O, compare with wild type in M; arrowheads delineate
the expression domain), whereas nlk* RNA (N) does not.